Chemical synthesis of the 5-taurinomethyl(-2-thio)uridine modified anticodon arm of the human mitochondrial tRNALeu(UUR) and tRNA Lys

RNA

Volumn 20, Issue 6, 2014, Pages 938-947

  Leszczynska, Grazyna ^a   Leonczak, Piotr ^a   Wozniak, Karolina ^a   Malkiewicz, Andrzej ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

5 taurinomethyl 2 thiouridine; 5 taurinomethyluridine; Human mitochondrial tRNA; Modified ribonucleosides; Phosphoramidite chemistry

Indexed keywords

5 TAURINOMETHYL(2 THIO)URIDINE; LEUCINE TRANSFER RNA; LYSINE TRANSFER RNA; MITOCHONDRIAL RNA; OLIGOMER; OLIGORIBONUCLEOTIDE; PHOSPHORAMIDOUS ACID; SULFONIC ACID DERIVATIVE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ANTICODON; ARTICLE; CHEMICAL STRUCTURE; DESULFURIZATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MITOCHONDRION; OXIDATION; PRIORITY JOURNAL; RNA SEQUENCE; SYNTHESIS;

5-TAURINOMETHYL-2-THIOURIDINE; 5-TAURINOMETHYLURIDINE; HUMAN MITOCHONDRIAL TRNA; MODIFIED RIBONUCLEOSIDES; PHOSPHORAMIDITE CHEMISTRY;

ANTICODON; HUMANS; MITOCHONDRIA; MUTATION; NUCLEIC ACID CONFORMATION; OLIGORIBONUCLEOTIDES; RNA, TRANSFER, LEU; RNA, TRANSFER, LYS; THIOURIDINE;

EID: 84901422098     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.044412.114     Document Type: Article

References (52)

1. Agris PF, Malkiewicz A, Kraszewski A, Everett K, Nawrot B, Sochacka E,Jankowska J, Guenther R. 1995. Site-selected introduction of modifiedpurine and pyrimidine ribonucleosides into RNA by automatedphosphoramidite chemistry. Biochimie 77: 125-134.
2. Ali AM, Hill B, Taylor SD. 2009. Trichloroethyl group as a protectinggroup for sulfonates and its application to the synthesis of a disulfonateanalog of the tyrosine sulfated PSGL-143-50 peptide. J Org Chem74: 3583-3586.
3. Andrianov AK, Marin A, Chen J, Sargent J, Corbett N. 2004. Novel routeto sulfonated polyphosphazenes: single-step synthesis using " noncovalentprotection" of sulfonic acid functionality. Macromolecules 37:4075-4080.
4. Avitabile BG, Smith CA, Judd DB. 2005. Pentafluorophenyl sulfonateester as a protecting group for the preparation of biaryl- and heterobiarylsulfonate esters. Org Lett 7: 843-846. (Pubitemid 40380240)
5. Bajji AC, Davis DR. 2002. Synthesis of the tRNALys,3 anticodon stem-loop domain containing the hipermodified ms2t6A nucleoside. JOrg Chem 67: 5352-5358. (Pubitemid 34793208)
6. Bajji AC, Sundaram M, Myszka DG, Davis DR. 2002. An RNA complexof the HIV-1 A-loop and tRNALys,3 is stabilized by nucleoside modifications.J Am Chem Soc 124: 14302-14303.
7. Baxter NJ, Rigoreau LJM, Laws AP, Page MI. 2000. Reactivity and mechanismin the hydrolysis of β-sultams. J Am Chem Soc 122: 3375-3385.
8. Bilbille Y, Vendeix FAP, Guenther R, Malkiewicz A, Ariza X, Vilarrasa J,Agris PF. 2009. The structure of the human tRNALys3 anticodonbound to the HIV genome is stabilized by modified nucleosidesand adjacent mismatch base pairs. Nucleic Acids Res 37: 3342-3353.
9. Boudou V, Langridge J, Van Aerschot A, Hendix C, Millar A, Weiss P,Herdewijn P. 2000. Synthesis of the anticodon hairpin tRNAf Metcontaining N-{[9-(β-D-ribofuranosyl)-9H-purin-6-yl]carbamoyl}-L-threonine (=N6-{{[(1S,2R)-1-Carboxy-2-hydroxypropyl]amino}carbonyl} adenosine, t6A). Helv Chim Acta 83: 152-161.
10. Cantara WA, Bilbille Y, Kim J, Kaiser R, Leszczynska G, Malkiewicz A,Agris PF. 2012. Modifications modulate anticodon loop dynamicsand codon recognision of E.coli tRNAArg1,2. J Mol Biol 416: 579-597.
11. Cantara WA, Murphy FV IV, Demirci H, Agris PF. 2013. Expanded useof sense codons is regulated by modified cytidines in tRNA. Proc NatlAcad Sci 110: 10964-10969.
12. Capaldi DC, Gaus H, Krotz AH, Arnold J, Carty RL, Moore MN, Scozzari AN, Lowery K, Cole DL, Ravikumar VT. 2003. Synthesisof high-quality antisense drugs. Addition of acrylonitrile to phosphorothioateoligonucleotides: adduct characterization and avoidance.Org Process Res Dev 7: 832-838.
13. Damha MJ, Ogilvie KK. 1993. Oligoribonucleotide synthesis. The silylphosphoramiditemethod. Methods Mol Biol 20: 81-114.
14. Duram PC, Bajji AC, Sundaram M, Kumar RK, Davis DR. 2005.Structural effects of hypermodified nucleosides in the Escherichiacoli and human tRNALys anticodon loop: the effect of nucleosidess2U, mcm5U, mcm5s2U, mnm5s2U, t6A and ms2t6A. Biochemistry44: 8078-8089.
15. Eshete M, Marchbank MT, Deutscher SL, Sproat B, Leszczynska G,Malkiewicz A, Agris PF. 2007. Specificity of phage display selectedpeptides for modified anticodon stem and loop domains of tRNA.Protein J 26: 61-73.
16. Florentz C, Sohm B, Tryoen-Tóth P, Pütz J, Sissler M. 2003. Human mitochondrialtRNAs in health and disease. Cell Mol Life Sci 60:1356-1375.
17. Gehrke CW, Kuo KC. 1989. Ribonucleoside analysis by reversed-phasehigh- performance liquid chromatography. J Chromatogr 471: 3-36. (Pubitemid 19144813)
18. Gehrke CW, Kuo KC, McCune RA, Gerhardt KO. 1982. Quantitativeenzymatic hydrolysis of tRNAs: reversed-phase high-performanceliquid chromatography of tRNA nucleosides. J Chromatogr BBiomed Sci Appl 230: 297-308. (Pubitemid 12058025)
19. Helm M, Brulé H, Friede D, Giegé R, Pütz J, Florentz C. 2000. Search forcharacteristic structural features of mammalian mitochondrialtRNAs. RNA 6: 1356-1379.
20. Hussain M, Ahmed V, Hill B, Ahmed Z, Taylor SD. 2008. A re-examinationof the difluoromethylenesulfonic acid group as a phosphotyrosinemimic for PTP1B inhibition. Bioorg Med Chem 16:6764-6777.
21. Jühling E, Pütz J, Florentz C, Stadler PF. 2012. Armless mitochondrial tRNAs in Enoplea (Nematoda). RNA Biol 9: 1161-1166.
22. Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K,Suzuki T. 2004. Codon-specific translational defect caused by a wobblemodification deficiency in mutant tRNA from a human mitochondrialdisease. Proc Natl Acad Sci 101: 15070-15075. (Pubitemid 39391720)
23. Klamann D, Hofbauer G. 1953. Reduktive Spaltungen von Sulfamiden.Chem Ber 86: 1246-1252.
24. Klán P, Pelliccioli AP, Pospíšil T, Wirz J. 2002. 2,5-dimethylphenacyl esters:a photoremovable protecting group for phosphates and sulfonicacids. Photochem Photobiol Sci 1: 920-923. (Pubitemid 37069819)
25. Kurata S, Weixlbaumer A, Ohtsuki T, Shimazaki T, Wada T, Kirino Y,Takai K, Watanabe K, Ramakrishnan V, Suzuki T. 2008. Modifieduridines with C5-methylene substituents at the first position of thetRBA anticodon stabilize U·G wobble pairing during decoding. JBiol Chem 283: 18801-18811.
26. Kurschat WC, Muller J, Wombacher R, Helm M. 2005. Optimizingsplinted ligation of highly structured small RNAs. RNA 11: 1909-1914. (Pubitemid 41720039)
27. Leszczynska G, Piȩta J, Sproat B, Malkiewicz A. 2011. Chemical synthesisof an RNA sequence containing 2-thiocytidine (s2C): theDY647 labelled anticodon stem and loop sequence of Staphylococcusaureus tRNAArg (s2C32, mnm5U34, t6A37). Tetrahedron Lett 52: 4443-4447.
28. Leszczynska G, Piȩta J, Leonczak P, Tomaszewska A, Malkiewicz A.2012. Site-specific incorporation of 5-methylaminomethyl-2-thiouridineand 2-thiouridine(s) into RNA sequences. Tetrahedron Lett53: 1214-1217.
29. Leszczynska G, Leonczak P, Dziergowska A, Malkiewicz A. 2013. mttRNAcomponents: synthesis of (2-thio)uridines modified withblocked glycine/taurine moieties at C-5,1. Nucleosides NucleotidesNucleic Acids 32: 599-616.
30. Lusic H, Gustilo EM, Vendeix FA, Kaiser R, Delaney MO, Graham WD,Moye VA, CantaraWA, Agris PF, Deiters A. 2008. Synthesis and investigationof the 5-formylcytidine, modified anticodon stem andloop of the human mitochondrial tRNAMet. Nucleic Acids Res 36:6548-6557.
31. Malkiewicz A, Sochacka E. 1983. The protected derivatives of 5-methylaminomethyl-2-thiouridine and 5-carbomethoxymethyl-2-thiouridineas components for the oligonucleotide synthesis. TetrahedronLett 24: 5387-5390.
32. Miller SC. 2010. Profiling sulfonate ester stability: identification of complementaryprotecting groups for sulfonates. J Org Chem 75: 4632-4635.
33. Myerscough PM, Fairbanks AJ, Jones AH, Bruce I, Choi SS,Fleet GWJ, Al-Daher SS, di Bello IC, Winchester B. 1992. Inhibitionof α-mannosidases by seven carbon sugars: synthesis of some sevencarbon analogues of mannofuranose. Tetrahedron 48: 10177-10190.
34. Ogata T, Wada T. 2006. Chemical synthesis of RNA including 5-taurinomethyluridine.Nucleic Acids Symp Ser 50: 9-10.
35. Ogata T, Wada T. 2008. Chemical synthesis of RNA including 5-taurinomethyluridineand 5-taurinomethyl-2-thiouridine. Nucleic AcidsSymp Ser 52: 323-324.
36. Okamoto I, Seio K, Sekine M. 2006. Improved synthesis of oligonucleotidescontaining 2-thiouridine derivatives by use of diluted iodinesolution. Tetrahedron Lett 47: 583-585. (Pubitemid 41797403)
37. Richman JE, Atkins TJ. 1974. Nitogen analogs of crown ethers. J AmChem Soc 96: 2268-2270.
38. Roberts JC, Gao H, Gopalsamy A, Kongsjahju A, Patch RJ. 1997. Neopentylester protecting groups for arylsulfonic acids. Tetrahedron Lett38: 355-358. (Pubitemid 27034062)
39. Seeberger S, Griffin RJ, Hardcastle IR, Golding BT. 2007. A new strategyfor the synthesis of taurine derivatives using the 'safety-catch' principlefor the protection of sulfonic acids. Org Biomol Chem 5:132-138.
40. Seio K, Wada T, Sakamoto K, Yokoyama S, Sekine M. 1998. Chemicalsynthesis and properties of conformationally fixed diuridine monophosphatesas building blocks of the RNA turn motif. J Org Chem63: 1429-1443. (Pubitemid 128496320)
41. Sissler M, Lorber B, Messmer M, Schaller A, Pütz J, Florentz C. 2008.Handling mammalian mitochondrial tRNAs and aminoacyl-tRNAsynthetases for functional and structural characterization. Methods44: 176-189. (Pubitemid 351172814)
42. Sochacka E. 2001. Efficient assessment of modified nucleoside stabilityunder conditions of automated oligonucleotide synthesis: characterizationof the oxidation and oxidative desulfurization of 2-thiouridine.Nucleosides Nucleotides Nucleic Acids 20: 1871-1879.
43. Sproat BS. 2005. RNA synthesis using 2′-O-(tert-butyldimethylsilyl) protection. Methods Mol Biol 288: 17-31.
44. Sundaram M, Crain PF, Davis DR. 2000. Synthesis and characterizationof the native anticodon domain of E. coli tRNALys: simultaneous incorporationof modified nucleosides mnmn5s2U, t6A, and pseudouridineusing phosphoramidite chemistry. J Org Chem 65:5609-5614.
45. Suzuki T, Nagao A, Suzuki T. 2011a. Human mitochondrial diseasescaused by lack of taurine modification in mitochondrial tRNAs.WIREs RNA 2: 376-386.
46. Suzuki T, Nagao A, Suzuki T. 2011b. Human mitochondrial tRNAs:biogenesis, function, structural aspects, and diseases. Annu RevGenet 45: 299-329.
47. Wada T, Shimazaki T, Nakagawa S, Otuki T, Kurata S, SuzukiT, Watanabe K, Saigo K. 2002. Chemical synthesis of noveltaurine-containing uridine derivatives. Nucleic Acids Res Suppl 2:11-12.
48. Watanabe K. 2010. Unique feature of animal mitochondrial translationsystems. The non-universal genetic code, unusual features of thetranslational apparatus and their relevance to human mitochondrialdiseases. Proc Jpn Acad Ser B Phys Biol Sci 86: 11-39.
49. Weixlbaumer A, Murphy FV IV, Dziergowska A, Malkiewicz A,Vendeix FAP, Agris PF, Ramakrishnan V. 2007. Mechanism forexpanding the decoding capacity of transfer RNAs by modificationof uridines. Nat Struct Mol Biol 14: 498-502.
50. Wende S, Platzer EG, Jühling F, Pütz J, Florentz C, Stadler PF, Mörl M.2014. Biological evidence for the world's smallest tRNAs. Biochimie100: 151-158.
51. Wrobel J, Rogers J, Green D, Kao W. 2002. Use of an isopropyl estermoiety as a sulfonic acid protecting group in a greatly improved synthesisof an arylsulfonic acid-based follicle stimulating hormone antagonist.Synth Commun 32: 2695-2704.
52. Yan L, Müller CE. 2004. Preparation, properties, reactions, and adenosinereceptor affinities of sulfophenylxanthine nitrophenyl esters:toward the development of sulfonic acid prodrugs with peroral bioavailability.J Med Chem 47: 1031-1043.